The World Health Organization (WHO) has prequalified a new vaccine for dengue developed by TakedaPharma, providing another tool against the vector-borne disease. Dengue, transmitted by mosquitoes, affects over 100-400 million people globally annually.
The World Health Organisation (WHO) this week pre-qualified a new vaccine for a mosquito-borne disease called –Dengue, which is mostly reported in the coastal part of Kenya. https://t.co/DHcX9MEbTH
WHO prequalifies new dengue vaccine https://t.co/m2xSaPB3op
WHO prequalifies new dengue vaccine, but Africa still not in the picture https://t.co/DxeMVyQzpW https://t.co/cUWEZKMziT
#Dengue | What causes Dengue and how can it be prevented? #HealthCare #HealthTips https://t.co/ZBdIkdtN8Z
WHO prequalifies second dengue vaccine: Know all about it https://t.co/WK7gwEnMTu
The World Health Organization (WHO) said on Wednesday that it had cleared a new #dengue vaccine, giving international agencies another option against the disease that affects millions of people each year. https://t.co/oZJg7ZvaMP
New #vaccine for #dengue developed by @TakedaPharma received prequalification from @WHO Dengue is a vector-borne disease transmitted by the bite of an infected mosquito and there are over 100-400 million cases worldwide each year https://t.co/lIVr1Linjz